Letter of no objection to FDA's approval of probiotic wheat bran extract
-
Last Update: 2010-12-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Fugeia announced that the company's Brana Vita (TM) bran extract has received a letter of Generally Recognized As Safe (GRAS) from the U.S Food and Drug Administration (FDA) This innovative product is rich in Axos (arabinose based xylan) extracted from cell wall and is one of the natural soluble fiber components Axos contained in Brana Vita (TM) is a powerful probiotic, which can promote the growth of bifidobacteria and other beneficial E.coli Due to the presence of Axos polymerized polyphenols, the component also has strong antioxidant activity As a result, fugeia's products can meet the needs of food companies eager to produce delicious food containing wheat bran extract, thus bringing benefits to consumers' health Willem broekaert, chief technology officer of the company, said: "the fact that Brana Vita (TM) has a generally recognized security certification highlights its security This is in line with its source, wheat bran, a healthy food ingredient with a long history of safe consumption This certification clears the way for our ingredients to become commercially regulated in the United States Authorities in several countries place a high value on generally recognized security certification, so this means an important step in our overall strategy of regulatory approval in all major markets around the world " Herman Van mellaert, CEO of the company, added: "this is an important milestone for us and our customers who are preparing to launch products in the United States Food companies want to differentiate their products by providing consumers with delicious taste and special health benefits We achieve these goals by providing consumers with natural ingredients from reliable sources through Brana Vita (TM) The results of all kinds of food are encouraging Our partners also attach great importance to the scientific basis we provide to support this significant commercial launch "
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.